Autolus Therapeutics (NASDAQ: AUTL) CEO Itin reports Form 3 holdings
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
Autolus Therapeutics plc director and Chief Executive Officer Christian Itin filed an initial Form 3 reporting his equity holdings. He directly owns 1,116,009 Ordinary Shares and 50,000 American Depositary Shares, each currently representing one Ordinary Share.
He also holds multiple share options over American Depositary Shares with exercise prices between 1.46 and 30.29 per share and expirations from 2028 through 2036, plus 350,000 restricted share units that vest in four equal annual installments commencing on January 26, 2027.
Positive
- None.
Negative
- None.
Insider Trade Summary
13 transactions reported
Mixed
13 txns
Insider
Itin Christian
Role
Chief Executive Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | American Depositary Shares | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Restricted Share Units | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
Holdings After Transaction:
American Depositary Shares — 50,000 shares (Direct);
Share Option (right to buy) — 131,868 shares (Direct);
Restricted Share Units — 350,000 shares (Direct);
Ordinary Shares — 1,116,009 shares (Direct)
Footnotes (1)
- The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one ordinary share. Each American Depositary Share is convertible at any time at the option of the Reporting Person into one Ordinary Share. Fully vested and exercisable. This option vested 25% on July 22, 2023 and the remainder vested or vests in 36 equal monthly installments thereafter. This option vested 25% on March 6, 2024 and the remainder vested or vests in 36 equal monthly installments thereafter. This option vested 25% on October 12, 2024 and the remainder vested or vests in 36 equal monthly installments thereafter. This option vested 25% on March 14, 2026 and the remainder vests in 36 equal monthly installments thereafter. This option vests 25% on January 26, 2027 and the remainder vests in 36 equal monthly installments thereafter. The restricted share units ("RSUs") vest in four equal annual installments commencing on January 26, 2027. Each RSU represents a contingent right to receive one Issuer American Depositary Share.
FAQ
What does the Autolus Therapeutics (AUTL) Form 3 filing show for CEO Christian Itin?
The Form 3 shows Christian Itin’s initial reported ownership in Autolus Therapeutics. He directly holds 1,116,009 Ordinary Shares, 50,000 American Depositary Shares, several share option awards over additional ADS, and 350,000 restricted share units that vest annually starting January 26, 2027.
What derivative awards does Christian Itin hold in Autolus Therapeutics (AUTL)?
Christian Itin holds multiple share options over Autolus American Depositary Shares. These options have exercise prices ranging from 1.46 to 30.29 per share and expiration dates between 2028 and 2036, reflecting long-dated equity incentives tied to the company’s ADS.
Are Christian Itin’s Autolus (AUTL) holdings direct or indirect in this Form 3?
All of Christian Itin’s reported holdings in this Form 3 are direct. The entries list ownership type and nature of ownership as direct, with no indication of indirect holdings through entities or trusts in the provided disclosure and footnotes.
Does the Autolus (AUTL) Form 3 show any recent insider buying or selling by Christian Itin?
The Form 3 functions as an initial ownership report rather than a trade report. The transactions are labeled as holdings with unknown transaction codes, and the transaction summary shows no buy, sell, or exercise activity in the data provided.